1. Chia S, Senatore F, Raffel OC et al (2008), “Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction”, JACC Cardiovasc Interv, 1(4):415-23.
2. Graham S. Hillis, Jacob E.Moller, (2004), “Noninvasive estimation of left ventricular filling pressure by E/e’ is a powerful predictor of survival after acute myocardial infarction”, J Am Coll cardiol, 43:360-367.
4. Khan SQ, Quinn P, Davies JE and Ng LL (2008), “N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction”, Heart, 94, pp.40–43.
5. Stone GW, Brodie BR, Morice MC et al (1998), “Prospective, multicenter study of the safety and feasibility of primary stending in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial”, J Am Coll Cardiol, 31, 23 – 30.
6. Nguyễn Quang Tuấn (2004), “Nghiên cứu hiệu qủa của phương pháp can thiệp động mạch vành qua da trong điều trị nhồi máu cơ tim cấp”, Luận án tiến sỹ Y học, 1 - 123.
7.
7. Tzivoni D, Koukoui D, Guetta V, Novack L, Cowing G; CASTEMI Study Investigators (2008), “Comparison of TroponinT to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty”, Am J Cardiol;101(6):753-7.
Tác giả
Trần Quang Định: Bệnh viện Đa khoa tỉnh Quảng Ninh;
Nguyễn Hồng Hạnh: Trường Cao đẳng Y tế Quảng Ninh;